Osteogenic protein-1 (OM; BMP7) is a member of the bone morphogenetic protein subfamily. Because members of the TGF-p superfamily have a role in tissue development, the distribution of OP1 expression in developing human embryos (5-8 gestational weeks) and fetuses (8-14 gestational weeks) and mouse (9.5-17.5 gestational days) fetuses was examined. Northern hybridization with specific OB1 probes revealed two mRNA species of 4 and 2.2 KFI. Highest levels of OP1 mRNA were found in human fetal kidney and heart between 12-14 weeks of gestation. By in situ hybridization, the OP-1 transcripts were found in various tissues, i.e., the ectodermal epithelium of the mouse fore-and hindlimbs, heart, teeth, intestinal epithelium, perichondrium, hyper-
Introduction
The transforming growth factor-beta (TGF-p) superfamily members are signaling molecules that play a role in morphogenesis during embryonic development. Members of this family encode secreted polypeptides that share common structural features. They are proteolytically processed from the pro-protein to yield the carboxy terminal mature protein of approximately 110 amino acids. All members share a conserved pattern of cysteines in this domain. The active ligand form is a disulfide-bonded homodimer of a single family member or a heterodimer of two different members (19, 29) .
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Correspondence to: Slobodan Vukicwic, NIH, NIDR, Bldg. 10, Rm. 1 N 108, Bethesda, MD 20892. trophic chondrocgtes, and periosteumhteoblast layer of developing human bones. In kidneys, transcripts were first detected in the epithelium of the branching uretheric buds, whereas at later stages glomeruli were the major site of OP1 mRNA accumulation. These data suggest that, although OB1 has been isolated from bone matrix, it may have additional regulatory roles in the morphogenesis and/or function of the A number of members of this superfamily have been identified in various developmental systems. The decapentaplegic gene, dpp, is responsible for proper dorsoventral development of Drosophila melanogarter and may also be involved in gut morphogenesis (7, 11, 25) . Another Drosophila gene, 60 A, also appears to be expressed throughout early embryonic development (6, 40) . In Xenopus laevis, vegetal pole-derived transcripts of Vg-1 have been associated with induction of mesoderm (31, 39) , and activins have been demonstrated to play a critical role in mesoderm induction (9, 32) . Other members of the TGF-p superfamily that have been implicated in embryonic development include Mullerian inhibiting substance (MIS), which causes regression of the Mullerian ducts in the developing male reproductive tract (2), the mammalian inhibins and activins, which act together to regulate the release of folliclestimulating hormone in the pituitary gland (8J4.18). and the growth and differentiation factors (GDFs), which are possibly involved in neuron differentiation and nerve growth (13, 20) . Bone morphogenetic proteins BMP-2, BMP-3 (osteogenin), BMP-4, BMP-5, BMP-6 (Vg-1). osteogenic protein-1 (OP-1; BMP-7), and osteogenic protein-2 (BMP-8) have been implicated in cartilage and bone formation both in vitro and in vivo (3, 15, 22, 23, [27] [28] [29] [30] 34, 36, 38, 42) . There is accumulating evidence that morphogenetic proteins are important regulators of many morphogenetic events during embryogenesis. For example, recent in situ hybridization studies of BMP-2, BMP-4, and BMP-6 revealed, in addition to the expected localization of transcripts in cells involved in skeletal morphogenesis, mRNA transcripts in several extraskeletal organs and tissues, i.e., the developing limb, the myogenic layer of the atrioventricular cushions of the developing heart, developing hair and whisker follicles, tooth buds and palate, developing central nervous system, and craniofacial tissue (12J6.17). OP-1 was identified in human placenta and in brain cDNA libraries (24) and by Northern hybridization analysis BMP-3-6 mRNAs have all been found in the lung (23) . BMP-3 message was found by in situ hybridization in the perichondrium, periosteum/osteoblast layer, intestine, kidney, and especially lung, which is a major site of synthesis during human development (34).
By Northern analysis and immunohistochemistry, OP-1 was localized not only in osteogenic sites but also in kidney, adrenal, urinary bladder, developing heart, and a number of basement membranes separating the epithelium from the underlying stroma (22, 23, 35) . These findings prompted us to study OP-1 expression during human and mouse development, utilizing OP-1 specific riboprobes. The results show that OP-1 transcripts are present in a variety of tissues, suggesting local andlor systemic release, particularly in the development of kidney, limb bud, bone, tooth, heart, and intestine.
Materials and Methods
Human Tissue. Fifty-seven human embryos from 5-14 weeks of gestation [ 10-52 mm crown-rump length (CRL)] were used in the present study. The gestational age of each embryo was estimated in weeks (W) on the basis of CRL and pregnancy records of the conceptual age (21) . The procedure for the human autopsy material was approved and controlled by the Internal Review Board of the Ethical Committee at the School of Medicine, University of Zagreb and the Office of Human Subjects Research (OHSR) at the National Institute of Health, Bethesda, MD. The material was fixed at 4°C in 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.2). embedded in paraffin, and cut serially at 5 pm.
Mouse Tissue. Post-implementation embryos were obtained from outbred females mated with F1 males. Noon of the day the vaginal plug appears is considered to be 0.5 days p.c. Tissues were fixed at 4'C in 4% paraformaldehyde in PBS and embedded in paraffin. Serial sections were mounted on silanated glass slides, incubated overnight at 40-45'C, and stored at 4°C until use.
Probe Construction. For detection of human OP-1 (22) , two probe construcn were used a 679 BP EdU-BglI fragment (pU 320-5) covering amino acids 63-263 of the pro region and the first 25 amino acids of the N-terminal part of the mature polypeptide, and a shorter 248 BP PstI-StuI fragment ( p 8 341-7) covering amino acids 218-263 of the pro region and the first 36 amino acids of the N-terminal part of the mature polypeptide. The long fragment was subcloned into a pBluescript I1 (SK)' vector, from which the KpnI-Cla and SpeI-Sac1 multiple cloning site (MCS) fragments were eliminated to prevent cross-hybridization with ribosomal RNA sequences (41). whereas the shorter fragment was subcloned into a pGEM-2 vector. For detection of OF1 transcript in the mouse (24) , two different stretches, a 676 BP BstX-BglI-fragment (PO 319-3) covering essentially the same region as the human probe construct 1, and a 340 BP EarI-PstI fragment from the 3' non-coding region, were used. Based on the comparison ofOFl probes to other bone morphogenetic proteins, the identity did not exceed 29% before and after alkaline hydrolysis, making crossreactivity unlikely (GeneWorks 2.2.1.; IntelliGenetics, Mountainview, CA). To test the specificity of OP-1 expression, a BMP-3 probe from a pro region (34) was used in adjacent human and mouse selections. Single-stranded sense and anti-sense RNA probes were labeled with [u-~~SI-UTP (New England Nuclear; Boston, MA) by in vitro transcription using either SP6 or T7 polymerase.
In Situ Hybridization. For in situ hybridization, sections were cut at 5-7 pm thickness, mounted on silanated slides, heated at 45'C overnight, and kept at 4°C. They were then deparaffinized, rehydrated, and post-fixed for 20 min in 4% paraformaldehyde. Pre-treatment included incubation in 0.2 N HCI ( 5 min), proteinase K digestion (20 mglml, 10 min), additional post-fixation ( 5 min), blocking of nonspecific sulfur-binding sites with iodoacetamide (0.37 gl400 ml) and N-ethylmaleimide (0.25 gl400 ml), acetic anhydride treatment (0.5% in 0.1 M triethanolamine-HC1. pH 8.0, twice for 10 min), and dehydration using a graded series of ethanol. Sections were hybridized under siliconized coverslips for 16-18 hr at 50°C in a humid chamber in hybridization buffer [50% formamide, 10% dextran sulfate, 4 x SSC (SSC = 0.15 M NaCI, 0.015 M Na-Citrate, pH 7)], 10 mM dithiothreitol (MT), 1 x Denhardt, 500 pglml each of salmon sperm DNA and yeast tRNA, and 0.2-0.4 nglpl 3'S-labeled asymmetric RNA probes (4). After hybridization the sections were washed essentially as described by Pelton et al. (26) , including the following steps: 15 min in 2 x SSC, S O T ; 20 min in 50% formamide (2 x SSC, 20 mM DDT, 6S"C), 2 x 10 min in TEN buffer (10 mM %is-HCI, pH 7.5, 5 mM EDTA, 0.5 M NaCI, 37'C), 30 min in TEN buffer containing 20 pglml RNAse A, 37°C; 10 min in TEN buffer, 37°C; twice for 15 min in 2 x SSC. 65°C; and finally two 15-min washes in 0.1 x SSC, 65°C. Sections were then dehydrated through an upgraded series of ethanol containing 0.3 M NHdAc, covered with NTB-2 Kodak emulsion, and exposed for 1-3 weeks. After development, the slides were stained with 0.1% toluidine blue, dehydrated, cleaned with xylene, and mounted with Permount.
(BMP-2 27%). BMP-3 2846, BMP-4 26%. BMP-5 24%, BMP-6 29%, both Northern Hybtidization. Total RNA from mouse embryos and postnatal animals was prepared by the acid guanidine thiocyanate-phenol chloroform method ( 5 ) . The RNA was dissolved in TES buffer (1 mM Tris-HC1, 1 mM EDTA, 0.1% SDS, pH 7.5) and treated with proteinase K (1.5 mg/g tissue sample) at 45'C for 1 hr. Poly (A)' RNA was isolated using oligo-dT columns. Poly (A)' RNA (2 pgllane) was fractionated on 1% agarose-formaldehyde gels. Membranes were hybridized in Hybrizol at 42% for 48 hr, followed by washing at 24'C for 5 min and twice at 65'C for 15 min with PES buffer (40 mM NazHP04, 1 mM EDTA, 1% SDS). For re-use, the membranes were stripped off using 50% formamide in 6 x SSPE.
Results
To test the specificity of OP-1 distribution, the same Northern blots and adjacent human and mouse tissue sections were hybridized with BMP-3 probes giving a different expression pattern (34).
Tzssue-spec+c OPl mRNA Transcripts
OP-1 expression was analyzed in several tissues of 12-14-week human embryos by Northern hybridization. cDNA probes from a region other than the highly conserved 7-cysteine domain of OP-1 2.0-U a-- were used to avoid cross-hybridization of closely related genes. Northern analysis of poly (A)' RNA form human fetal tissues revealed essentially two major transcripts of approximately 2.2 and 4.0 KB in a number of embryonic tissues. These included kidney, brain, heart, and lung. Liver did not give any detectable signals ( Figure  1 ). Fetal kidney and heart appeared to be the major sites of OP-1 mRNA synthesis, thus extending the previous studies on postnatal mouse tissue in which kidney alone had been identified as the major site of OP-l production (24) . Only the larger mRNA size was detected in the brain at this developmental stage, whereas in lungs the smaller mRNA transcript was scarcely visible. The spatial localization of transcripts was then analyzed by in situ hybridization.
OP-1 Transcrzpts in Developing Mouse Limb Buds and Human Skeleton
The distribution of OP-1 transcripts in limb buds was examined in serial sections through murine development. At 9.5 days P.C. the mouse forelimb bud is adiscrete outgrowth from the body wall. Few OP-1 transcripts were localized in the epithelium of the ventral surface (Figure 2A ). At 10.5 days p.c. the majority of O F 1 transcripts were detected in the ectodermal surfaces of the fore-and hindlimb, maximally concentrated in the apical ectodermal ridge (AER) area ( Figure 2B ). Less intense, uniformly distributed expression was also detected in the underlying mesenchyme of the forelimb buds. A more uniform expression was observed in the limb bud mesoderm ( Figure 2B ). At later developmental stages (12.5-14.5 days P.c.), OP-1 transcripts were observed around the cartilage precondensations of developing bones (not shown). In human embryos at 7 weeks of gestation, OP-1 transcripts were localized to the perichondrium of the cartilaginous long bones ( Figure 3A) . They first appeared in chondrocytes during their terminal differentiation or chondrocyte hypertrophy at 8 and 9 weeks ( Figure 3B ). At later developmental stages. OP-1 transcripts were found in the periosteum/osteoblast layer of the osteogenic zone ( Figure 3C ; Table l ). 
OP-1 Transcripts in Developing Human ana' Mouse Kidney
The permanent kidney or metanephros arises from the mesonephric duct and from the nephrogenic cord. OF1 transcripts have been detected at 6 weeks of gestation in the metanephric mesenchyme surrounding the epithelium of the ureteric bud ( Figures 4A-4D ). At later developmental stages, high levels of OP-1 mRNA were present in the developing glomeruli and less in adjacent convoluted tubules and straight collecting ducts (Figures 4E and 4F) . On the contrary, the OP-1 protein staining was more pronounced in convoluted kidney tubules, as shown earlier (35). The same distribution of OF1 transcripts was detected in mice of 17.5 days p.c. with two different OP-1-specific riboprobes (Figures 5C and 5D ).
OP-1 Expression at Other Sites
In addition to the patterns of expression discussed above, OF1 RNA was detected in several other sites in both human and mouse tissue ('hble 1). For example, transcripts were present in cytouophoblasts of 3 to 12 gestational weeks in human placentas, in muscle ( Figures  3A and 3C) , and in gastrointestinal mucosa between 6 and 14 weeks ( Figure 4E ). In the 10.5-day p.c. mouse embryos, OP-1 transcripts were also detected in the developing heart, areas of olfactory plaque, and in the ophthalmic neural crest (Figure 2b) . In older embryos (12.5-18 .5 days P.c.), several craniofacial structures showed expression of OP-1, predominantly skin, hair follicles, nasal epithelium, teeth, calvaria, meninges, choroid plexus, and salivary glands ( Figures 5A, 5B, and 6) . As in human, the mouse gastrointestinal mucosa was also positive for OP-1 ( Figure 5D ).
Discussion
In the present study, the expression patterns of OP-1 in the human embryonic and part of the fetal period, and in mouse fetal development, were examined by Northern and in situ hybridization. The results obtained demonstrate unique patterns of OP-1 mRNA synthesis and localization, both spatially and temporally, in both developing species, compared with other members of the BMP family (10, 16, 17, 23, 34, 39) .
Two strongly expressed mRNA transcripts of 4 and 2.2 KB were found in human fetal kidney and heart at 12-14 weeks of gestation, with approximately equal intensities in both species, OP-1 expression has been previously described in these two organs, but with different relative intensities. In heart, OP-1 mRNA of 2-dayold rats was clearly detectable but was markedly lower than in kidney, whereas in 2-week-old and 6-9-month-old mice, expression in the heart appeared to be below the detection level (23, 24) . These data indicate that there might be both age-dependent and tissuedependent differences in OP-1 expression. In this study, we found that in heart, the relative expression level for OP-1 diminished with age but no differences in transcript sizes were observed. However, even though both transcripts were found in young and adult lung and brain, only the 4 KB size was detected in their fetal counterparts. Like OP-1, most TGFD superfamily members show multiple transcripts, because of multiple promoters that result in messages that differ at the 5' end, alternative splicing events, altemative polyadenylation sites, or they may represent transcripts from several closely related genes. We have recently sequenced the 4 KB OP-1 message of a cDNA clone from a mouse teratocarcinoma cDNA library. The 3' untranslated sequence downstream of the translational stop codon is the same as for the 2 KB mRNA. Beyond that point, their extended sequences are identical except for variations in length. This finding proved that the 2 and 4 KB mRNAs are transcripts from the same OP-1 locus rather than from multiple genes (bzkaynak et al., manuscript in preparation).
To date, the different BMPs have been reported to induce bone formation at ectopic, non-skeletal sites (subcutaneous or intramuscular) when implanted together with an appropriate collagenous matrix (37). The observed bone developmental cascade is reminiscent of embryonic endochondral bone formation in the limb bud (1) and also displays many similarities with the processes that take place during callus formation and fracture repair. Recent studies utilizing in situ hybridization have shown that BMP-2 is expressed in the apical ectodermal ridge (AER) and the pre-cartilaginous mesenchyme in the early limb bud, while BMP-6 (Vgr-1) is highly expressed in hypertrophic chondrocytes of more developed bone structures (17) . The present data show that OP-l was already expressed in theectodermal epithelium and the AER during the first stages of limb bud development, and then progressively shifted to the pre-condensing mesenchyme and to the perichondrium of the cartilaginous long bones. Long bone chondroblasts. themselves not positive for OP-1. began to express specific OP-l mRNA when they terminally differentiated into hypertrophic chondrocytes before bone formation. Finally, OP-l transcripts became localized to the periosteum/osreoblast laycr during new bone formation. The presence of OP-l in early devcloping limbs, its absence in chondroblasts. and its reappearance during subsequent chondrocyte hypcrtrophy and ossification. collectively suggest that OP-1 is locally produced and that it might have. alone or in concert with other BMPs. an organizational role in the development of long bones. Several BMPs may be involved, apart from their independent ability to induce bone at skeletal sites. in the regulation of skeletal embryogenesis.
By using in situ hybridization. wc were also able to analyze in more derail the spatial and temporal expression of OP-I patterns in extraskeletal sites. In addition to the tissues previously shown by Northern hybridization to express OP-l (23.24; and this study). we found several other OP-1-positive sites. These included gastrointestinal mucosa, muscle. whisker follicles. skin. teeth, and some other craniofacial structures. The widespread distribution of OP-l expression correlates with development as a result of epithelial/ mesenchymal interaction. Detection of OP-1 message in tissues such as kidney. heart. early limb buds, whisker follicles. and teeth indicates that OP-l may have. apart from bone induction. important mediating or regulatory roles in epithelial/mesenchymal signaling. This has been previously suggested for other bone morphogenetic protein family members (16,172.3) .
Because the developing kidney is a well-known model in which to study inductive interactions. we decided to analyze the OP-1 expression in more detail. The permanent vertebrate kidney or H E " . 6)zKAYNAK, SAMPATH, LUYTEN, WTIN, OPPERMA", WKICEVIC whereas only a few cells are positive in the dental pulp (dp). (a) No expression is found in a tooth hybridized with a senseprobe. Bar = 50 pm.
metanephros arises from the ureteric bud, a folding of the mesonephric duct, and from the nephrogenic cord. Previous studies have shown that, for correct kidney development, inductive interactions between the ureteric bud and its surrounding metanephrogenic mesenchyme are critical. Our results indicated that at the same time point when these developmentally important interactions occur. OP-1 is highly expressed in one of the tissues involved, the metanephrogenic mesenchyme. At later developmental stages, OP-1 expression shifted and was mainly located in developing kidney glomeruli. These observations suggest that OP-1 may indeed func-tion as a diffusible mediator of inductive signals between different cell layers. Interestingly, we observed earlier that OP-l protein was mainly localized to kidney convoluted tubules and less to glomeruli (33). This discrepancy from the expression pattern means that OP-1 is locally transported to the epithelium of the nephron or is systemically released from the glomerular epithelial and endothelial cells, with subsequent accumulation in the tubule compartment. Preliminary data suggest that OP-1 may be systemically released, i.e., it accumulates in basement membranes of underlying epithelium that is not producing OP-1 (35) .
Taken together, our results show that OP-l is expressed in initial stages of limb bud development, suggesting important roles in the initiation and/or progression of limb formation. In addition, OP-1 may be involved in the terminal differentiation of chondrocytes and subsequent bone formation. Our study also identified embryonic heart and kidney as major extraskeletal sites of OP-1 synthesis.
